biote Corp
General ticker "BTMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $200.4M
biote Corp follows the US Stock Market performance with the rate: 34.4%.
Estimated limits based on current volatility of 3.6%: low 5.76$, high 6.19$
Factors to consider:
- Current price 27.9% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.14$, 4.76$]
- 2023-12-31 to 2024-12-30 estimated range: [2.04$, 4.53$]
Short-term BTMD quotes
Long-term BTMD plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $116.57MM | $0.00MM | $159.87MM |
| Operating Expenses | $84.79MM | $3.32MM | $220.59MM |
| Operating Income | $31.78MM | $-3.32MM | $-60.72MM |
| Non-Operating Income | $-2.43MM | $14.43MM | $62.43MM |
| Interest Expense | $2.42MM | $1.67MM | $5.09MM |
| Income(Loss) | $29.35MM | $11.11MM | $1.71MM |
| Taxes | $0.19MM | $0.00MM | $0.39MM |
| Profit(Loss) | $29.16MM | $11.11MM | $1.32MM |
| Stockholders Equity | $0.03MM | $-22.63MM | $-44.46MM |
| Assets | $0.15MM | $318.03MM | $111.64MM |
| Operating Cash Flow | $26.43MM | $33.72MM | $-9.16MM |
| Capital expenditure | $1.39MM | $3.81MM | $1.84MM |
| Investing Cash Flow | $-1.39MM | $-3.81MM | $-1.84MM |
| Financing Cash Flow | $-18.32MM | $-20.34MM | $63.46MM |
| Earnings Per Share* | $3.85 | $0.87 | $0.16 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.